Left ventricular unloading during extracorporeal membrane oxygenation - Impella versus atrial septal defect: A simulation study.


Journal

The International journal of artificial organs
ISSN: 1724-6040
Titre abrégé: Int J Artif Organs
Pays: United States
ID NLM: 7802649

Informations de publication

Date de publication:
Oct 2020
Historique:
pubmed: 25 2 2020
medline: 10 2 2021
entrez: 25 2 2020
Statut: ppublish

Résumé

Atrial septal defect and Impella have been proposed for left ventricular unloading in venoarterial extracorporeal membrane oxygenation patients. This work aims at evaluating the haemodynamic changes in venoarterial extracorporeal membrane oxygenation patients after Impella implantation or atrial septal defect realization by a simulation study. A lumped parameter model of the cardiovascular system was adapted to this study. Atrial septal defect was modelled as a resistance between the two atria. Venoarterial extracorporeal membrane oxygenation and Impella were modelled starting from their pressure-flow characteristics. The baseline condition of a patient undergoing venoarterial extracorporeal membrane oxygenation was reproduced starting from haemodynamic and echocardiographic data. The effects of different atrial septal defect size, Impella and venoarterial extracorporeal membrane oxygenation support were simulated. Impella caused an increment of mean arterial pressure up to 67%, a decrement in mean pulmonary arterial pressure up to 8%, a decrement in left ventricular end systolic volume up to 11% with a reduction up to 97% of left ventricular cardiac output. Atrial septal defect reduces left atrial pressure (19%), increases right atrial pressure (22%), increases mean arterial pressure (18%), decreases left ventricular end systolic volume (11%), increases right ventricular volume (33%) and decreases left ventricular cardiac output (55%). Impella has a higher capability in left ventricular unloading during venoarterial extracorporeal membrane oxygenation in comparison to atrial septal defect with a lower right ventricular overload.

Sections du résumé

BACKGROUND BACKGROUND
Atrial septal defect and Impella have been proposed for left ventricular unloading in venoarterial extracorporeal membrane oxygenation patients. This work aims at evaluating the haemodynamic changes in venoarterial extracorporeal membrane oxygenation patients after Impella implantation or atrial septal defect realization by a simulation study.
METHODS METHODS
A lumped parameter model of the cardiovascular system was adapted to this study. Atrial septal defect was modelled as a resistance between the two atria. Venoarterial extracorporeal membrane oxygenation and Impella were modelled starting from their pressure-flow characteristics. The baseline condition of a patient undergoing venoarterial extracorporeal membrane oxygenation was reproduced starting from haemodynamic and echocardiographic data. The effects of different atrial septal defect size, Impella and venoarterial extracorporeal membrane oxygenation support were simulated.
RESULTS RESULTS
Impella caused an increment of mean arterial pressure up to 67%, a decrement in mean pulmonary arterial pressure up to 8%, a decrement in left ventricular end systolic volume up to 11% with a reduction up to 97% of left ventricular cardiac output. Atrial septal defect reduces left atrial pressure (19%), increases right atrial pressure (22%), increases mean arterial pressure (18%), decreases left ventricular end systolic volume (11%), increases right ventricular volume (33%) and decreases left ventricular cardiac output (55%).
CONCLUSION CONCLUSIONS
Impella has a higher capability in left ventricular unloading during venoarterial extracorporeal membrane oxygenation in comparison to atrial septal defect with a lower right ventricular overload.

Identifiants

pubmed: 32089039
doi: 10.1177/0391398820906840
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

663-670

Auteurs

Arianna Di Molfetta (A)

Department of Cardiac Surgery, Policlinico Gemelli-Catholic University of Rome, Rome, Italy.

Iki Adachi (I)

Department of Cardiac Surgery and The Lillie Frank Abercrombie Section of Cardiology, Texas Heart Hospital, Texas Children's Hospital, Houston, TX, USA.

Gianfranco Ferrari (G)

Nalecz Institute of Biocybernetics and Biomedical Engineering (IBBE) PAS, Warszawa, Poland.

Maria Giulia Gagliardi (MG)

Department of Pediatric Cardiology and Cardiac Surgery, Pediatric Hospital Bambino Gesù, Rome, Italy.

Gianluigi Perri (G)

Department of Cardiac Surgery, Policlinico Gemelli-Catholic University of Rome, Rome, Italy.

Roberta Iacobelli (R)

Department of Pediatric Cardiology and Cardiac Surgery, Pediatric Hospital Bambino Gesù, Rome, Italy.

Athar M Qureshi (AM)

Department of Cardiac Surgery and The Lillie Frank Abercrombie Section of Cardiology, Texas Heart Hospital, Texas Children's Hospital, Houston, TX, USA.

Luigi Di Pasquale (L)

Department of Cardiac Surgery and The Lillie Frank Abercrombie Section of Cardiology, Texas Heart Hospital, Texas Children's Hospital, Houston, TX, USA.

Rodrigo Zea Vera (RZ)

Department of Cardiac Surgery and The Lillie Frank Abercrombie Section of Cardiology, Texas Heart Hospital, Texas Children's Hospital, Houston, TX, USA.

Paolo Guccione (P)

Department of Pediatric Cardiology and Cardiac Surgery, Pediatric Hospital Bambino Gesù, Rome, Italy.

Matteo Di Molfetta (M)

Department of Cardiac Surgery, Policlinico Gemelli-Catholic University of Rome, Rome, Italy.

Giovanni Alfonso Chiariello (GA)

Department of Cardiac Surgery, Policlinico Gemelli-Catholic University of Rome, Rome, Italy.

Sergio Filippelli (S)

Department of Pediatric Cardiology and Cardiac Surgery, Pediatric Hospital Bambino Gesù, Rome, Italy.

Antonio Amodeo (A)

Department of Pediatric Cardiology and Cardiac Surgery, Pediatric Hospital Bambino Gesù, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH